| Ex-Date | Pay Date | Amount | Change |
|---|---|---|---|
| HK$0.1122 | 172.99% | ||
| HK$0.1122 | 172.99% | ||
| HK$0.0411 | -77.17% | ||
| HK$0.0411 | -77.17% | ||
| HK$0.18 | |||
Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H pays a dividend yield (FWD) of 2.79%.
- ISIN
- WKN
- Symbol / Exchange
- / XHKG
- Value
- €0.50
- Dividend frequency
- annually
- Security Type
- Equity
- Sector
Health Care
- Country
China
- Dividend Currency
- Hong Kong Dollar
- Earnings Date
- Within the last 12 months, Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H paid a dividend of HK$0.00. For the next 12 months, Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H is expected to pay a dividend of HK$0.11. This corresponds to a dividend yield of approximately 2.79%.
- The dividend yield of Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H is currently 2.79%.
- Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H pays annually dividends. Payout is in August.
- The next dividend for Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H is expected in August.
- Within the last 10 years, Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H has paid dividends in 3 of them.
- Dividends of HK$0.11 are expected for the next 12 months. This corresponds to a dividend yield of 2.79%.
- Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H is assigned to the sector "Health Care".
- There are currently no known stock splits for Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H.
- To receive the last dividend of Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H on 15 August 2023 in the amount of HK$0.11 you had to have the stock in your portfolio before the ex-day on 24 May 2023.
- The last dividend was paid on 15 August 2023.
- In 2022, dividends of HK$0.04 were paid by Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H.
- Dividends from Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H are paid in Hong Kong Dollar.
- The headquarters of Shenzhen Hepalink Pharmaceutical Group Co Ltd Class H is located in China.